Research and Markets (http://www.researchandmarkets.com/research/np9jnn/uveitis_global) has announced the addition of the "Uveitis Global Clinical Trials Review, H2, 2013" report to their offering.

Uveitis Global Clinical Trials Review, H2, 2013 provides data on the Uveitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Uveitis.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Uveitis Therapeutics Clinical Trials

  • Novartis AG
  • Bausch & Lomb Incorporated
  • Allergan, Inc.
  • Sirion Therapeutics, Inc.
  • Lux Biosciences, Inc.
  • AbbVie Inc.
  • XOMA Corporation
  • pSivida Corp.
  • EyeGate Pharmaceuticals, Inc.

Clinical Trial Overview of Top Institutes / Government

  • National Eye Institute
  • St. Franziskus Hospital
  • Oregon Health and Science University
  • Moorfields Eye Hospital NHS Foundation Trust
  • University of California, San Francisco
  • Johns Hopkins University
  • Institut de Recherches Internationales Servier
  • Assistance Publique - Hopitaux de Paris
  • Duke University
  • Medical University of Vienna

For more information visit http://www.researchandmarkets.com/research/np9jnn/uveitis_global

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals